CA-ENERO-GROUP
8.6.2021 15:02:15 CEST | Business Wire | Press release
Enero Group (ASX:EGG) has today announced the appointment of Heather Kernahan as Global Chief Executive Officer of Hotwire, the Group’s leading global technology communications consultancy. The appointment will see Kernahan report to Brent Scrimshaw, Enero Group CEO, effective 1 July 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210608005467/en/
Barbara Bates, who has successfully led Hotwire for the past five years, will move into a newly created senior advisory role at Enero. Bates will help facilitate Enero Group’s M&A activities in North America and will continue to report to Brent Scrimshaw.
“I would like to thank Barbara for her leadership and drive in Hotwire being the successful, global technology communications consultancy that it is today. She has been an innovative, respected and transformational leader across nearly three decades in the global communications industry. I am delighted she will remain in the Group.
“This change provides an excellent opportunity for Heather Kernahan to lead the next phase of growth for Hotwire. Heather has demonstrated incredible leadership in tackling the challenges and opportunities of a rapidly-growing business in Hotwire USA. Heather has the skills, experience and appetite for growth and her appointment demonstrates the deep bench strength of the Hotwire leadership team. I am confident she will continue to drive the business’ momentum and push Hotwire to even greater heights,” said Brent Scrimshaw.
Commenting on her appointment, Heather Kernahan said: “There is no more exciting industry to be in than technology and I’m thrilled to lead the Hotwire team as we continue to grow. We have ambitious plans to bring more value to our fast growth and global tech clients, who are looking for an alternative to the big multinational agencies. Barbara has led a culture, team and business that is sought after by the largest tech companies in the world and I’m honoured to now lead this organisation. With 20 years behind us, we feel that we’re just getting started.”
Barbara Bates said: “I’ve had the privilege to work with so many amazing people during my time at Hotwire, and I’m exceptionally proud of what we’ve managed to create together. Hotwire is already one of the world’s most highly-regarded tech communications businesses and with Heather’s leadership, it has never been better positioned to grow further. I’m excited to stay connected to the Enero Group and I look forward to continue building on the Group’s strong momentum and ambition.”
Heather Kernahan joined Hotwire from Eastwick Communications, as president of Hotwire North America and Australia, after its acquisition in 2016 by Enero Group. In 2019, she was named Hotwire CEO of North America. Under her leadership the agency has experienced record growth. With over 20 years of industry experience, Kernahan has held senior marketing and executive leadership roles at fast growth and global technology organisations including Autodesk, Enphase Energy and Alias. Under her leadership, Hotwire has developed partnerships with technology companies including: Adobe, Facebook, McAfee, Commvault, NetApp and Pinterest. As a global tech expert and business leader she has been named one of 2020 SF Business Times’ 100 Most Influential Women and is the Board Chair of The PR Council. Kernahan holds an MBA in Sustainable Enterprise from Dominican University of California.
This announcement comes as Hotwire continues to expand the team while delivering outstanding business results and following the successful acquisition of McDonald Butler Associates in London last month. In the past year, Hotwire has continued its 20 years of industry leadership, being named 2020 Global Technology Agency of the Year by PRovoke Media, Best Places to Work in PR by PRWeek for two years in a row and recently recognised as one of the Best Companies to Work for in the UK by the Sunday Times . Current clients include Accenture, Adobe, AWS, Citrix, Dell Technologies, Deloitte, Delphix, DXC Technology, eBay, GoPro, Honeywell, IBM, McAfee, Pegasystems and PWC.
About Enero:
Headquartered in Sydney, Australia, Enero Group is a boutique network of marketing and communications businesses listed on the ASX (Australian Stock Exchange) that includes creative agency BMF, PR and integrated communications agencies Hotwire and CPR, strategic data consultancies The Leading Edge and The Digital Edge, digital agency Orchard and programmatic marketing specialist OB Media. www.enero.com .
About Hotwire
Hotwire is the global technology communication consultancy. Founded in 2000, we operate a worldwide network of wholly owned offices and partners serving a range of clients from scale ups to established multi-nationals. We unleash the possibilities of innovative technology through integrated communications that ignite curiosity, spark action and fuel success. We do this using our proprietary methodology which is underpinned by robust insight and strategy, purposeful creative, integrated planning and a core emphasis on measurement and evaluation. www.hotwireglobal.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210608005467/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release
Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom